Vergleich

YM201636 Europäischer Partner

ArtNr S1219-5
Hersteller Selleckchem
CAS-Nr. 371942-69-7
Menge 5 mg
Quantity options 10 mg 1 g 10 g 10 mM/1 mL 25 mg 5 mg 50 mg 5 g
Kategorie
Typ Inhibitors
Specific against other
Smiles C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 371942-69-7'
Similar products YM201636
Lieferbar
Manufacturer - Targets
PI3K
Storage Conditions
2 years -80 in solvent
Molecular Weight
467, 48
IC50
33 nM [1], 33 nM [1], 33 nM [1], 33 nM [1], 33 nM [1], 33 nM [1]
In vitro
YM201636 potently inhibits mammalian PIKfyve with an IC50 of 33 nM but not yeast orthologue Fab1 with an IC50 of >5 uM, exhibiting around 100-fold selectivity for PtdIns3P p110alpha with an IC50 of 3 uM. YM201636 (0.8 uM) significantly decreases the production of PtdIns(3, 5)P2 by 80% in serum-starved NIH3T3 cells followed by serum stimulation with no effect on serum-stimulated protein kinase B (PKB) Ser 473 phosphorylation. YM-201636 reversibly impairs endosomal trafficking in NIH3T3 cells by blocking PIKfyve and PtdIns(3, 5)P2 production, mimicking the effect produced by depleting PIKfyve with siRNA. YM-201636 (0.8 uM) also significantly reduces retroviruses budding from cells by 80%, apparently through interfering with the endosomal sorting complex required for transport (ESCRT) machinery. [1] In 3T3L1 adipocytes, YM-201636 inhibits basal and insulin-activated 2-deoxyglucose uptake with an IC50 of 54 nM, with almost complete inhibition at doses as low as 160 nM. YM-201636 (0.1 uM) has also been shown to completely block insulin-dependent activation of class IA PI 3-kinase. [2] Although not involved in NPM-ALK-dependent proliferation and migration, YM201636 (0.4 uM) strongly reduces invasive capacities of NPM-ALK-expressing cells and their capacity to degrade the extracellular matrix. [3] YM201636 treatment blocks the continuous recycling of junctional proteins claudin-1 and claudin-2 in MDCK cells, leading to the intracellular accumulation and delay of epithelial barrier formation. [4]
Kinase Assay
In vitro GST-PIKfyve assay, The assay is performed in kinase buffer (25 mM HEPES pH 7.4, 120 mM NaCl, 1.5 mM MgCl2, 5 mM 2-glycerophosphate, and 1 mM DTT) containing 100 uM PI(3)P, GST-PIKfyve, 50 uM ATP/10 uCi [32P]gammaATP and increasing concentrations of YM201636 in a final volume of 65 uL. The reactions are incubated for 15 minutes at 30 C, and stopped by the addition of 243 uL of 2:1 MeOH : CHCl3 (volume : volume). Lipid products labelled with 32P are analysed by thin-layer chromatography and quantified by Cerenkov counting. IC50 value is determined by using Graphpad Prism and errors are given as +/-95% confidence limit.
Solubility (25C)
DMSO 35 mg/mL, Water <1 mg/mL, Ethanol <1 mg/mL
Information
YM201636 is a selective PIKfyve inhibitor with IC50 of 33 nM, less potent to p110α and insensitive to Fabl (yeast orthologue). YM-201636 suppresses the growth of liver cancer via the induction of autophagy.
Chemical Name
3-Pyridinecarboxamide, 6-amino-N-[3-[4-(4-morpholinyl)pyrido[3', 2':4, 5]furo[3, 2-d]pyrimidin-2-yl]phenyl]-

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 5 mg
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?